10 August 2018 1 Min Read
EU says second Chinese firm’s heart drug is possibly carcinogenic
There could be one extra case of cancer for every 5,000 patients who took the tainted valsartan made by Zhejiang Huahai, based on taking the highest dose every day for seven years
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In